Community Based Rehabilitation Model After Total Knee Replacement

September 20, 2026 updated by: Tan Tock Seng Hospital

Community Based Rehabilitation Model After Total Knee Replacement: A Pilot Study

To investigate the clinical efficacy of community-based early stage knee replacement rehabilitation program as compared with usual care in acute hospital outpatient clinic

Study Overview

Detailed Description

To investigate the clinical efficacy of community-based early stage knee replacement rehabilitation program as compared with usual care in acute hospital outpatient clinic

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Singapore
      • Singapore, Singapore, Singapore
        • Tan Tock Seng Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

i) unilateral TKA; ii) age 55 years old and above; iii) able to engage in outpatient physiotherapy; iii) postoperative knee flexion ≥75° and knee extension ≤5°; iv) able to ambulate independently preoperatively.

Exclusion Criteria:

i) had revision TKA or fully constrained knee arthroplasty; ii) had knee replacement for indications other than osteoarthritis; iii) had post-operative complications during hospital stay; iv) were unable to participate due to cognitive impairment or language barriers; v) had acute spinal diseases or joint, muscle or systemic diseases affecting gait; iv) had comorbid health conditions that would prevent active participation (e.g. prior hemiplegic stroke, severe cardiorespiratory illnesses.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Outpatient

Usual care, outpatient physiotherapy

Physiotherapy at hospital

Active Comparator: CRC

Community based physiotherapy

Physiotherapy at community rehabilitation center

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 sec chair stand test
Time Frame: 0, 12 weeks

30 sec chair stand test score

0, 12 weeks
Passive knee flexion range
Time Frame: 0, 4, 12 weeks

Passive knee flexion range

0, 4, 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: 0,12 weeks

Pain intensity score

0,12 weeks
Oxford knee score
Time Frame: 0,12 weeks

Oxford knee score

0,12 weeks
Quadriceps muscle strength
Time Frame: 0,4,12 weeks

Quadriceps muscle strength, measured from 0 to 5 on Medical Research Council scale

0,4,12 weeks
EQ5D score
Time Frame: 0,12 weeks

EQ5D Visual Analog Score, EQ5D Utility score

0,12 weeks
Knee Society Score
Time Frame: 0,12 weeks

Knee Society Score

0,12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time up and Go
Time Frame: 3 months

Time up and go score

3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eng Chuan Neoh, Tan Tock Seng Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

July 1, 2022

Study Completion (Actual)

July 1, 2022

Study Registration Dates

First Submitted

February 14, 2024

First Submitted That Met QC Criteria

February 14, 2024

First Posted (Actual)

February 21, 2024

Study Record Updates

Last Update Posted (Actual)

September 24, 2026

Last Update Submitted That Met QC Criteria

September 20, 2026

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • DSRB 2019/01135

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe